Integral components of melanoma management include patient awareness of skin changes, as well as early and accurate identification, institution of treatment interventions, and high levels of expertise among members of the health care team. This webcast and the accompanying "Management of Early Melanoma and Atypical Spitz Tumors" provide clinicians and other health care professionals with the most recent, relevant research, treatment options, clinical data, guidance, and resources to optimize disease detection management, patient care, and overall health outcomes in dealing with melanoma.

Learning Objectives

At the end of this educational activity, participants should be able to:

  • Analyze clinical trial data on current and investigational treatment interventions to make informed, evidence-based decisions for individual patients with metastatic melanoma.

Target Audience

This program is intended for medical oncologists, surgical oncologists, dermatologists, oncology nurses, and other health care professionals who treat patients with melanoma.


  • Director of Developmental Therapeutics, Cancer Center/Medical Oncology, Massachusetts General Hospital
    Associate Professor of Medicine, Harvard Medical School
  • Clinical Director, Center for Melanoma, MGH
    Lecturer on Medicine, Harvard Medical School
  • Assistant in Surgery, Surgical Oncology, MGH
    Assistant Professor of Surgery, Harvard Medical School

CME Information



This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education. This activity has expired. CME/CE Released: 2/17/2011; Valid for credit through 2/17/2012.  

Credit Designation

Even though this event is no longer accredited, providing information regarding planning, disclosure, and conflict of interest is important to us. This activity was accredited by the Elsevier Office of Continuing Medical Education (EOCME). Please see the original CME information below:



Resolution of Conflict of Interest
The EOCME has implemented a process to resolve conflict of interest for each CME activity. In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, the EOCME has resolved the conflict by external content review.

Unapproved/Off-Label Use Disclosure
The EOCME requires CME faculty to disclose to the participants:
1. When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and
2. Any limitations on the information presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty may discuss information about pharmaceutical agents that is outside of FDA-approved labeling. This information is intended solely for CME and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.


The following planners of this activity have indicated that neither they nor their families have a significant financial interest or affiliation with the manufacturer of any commercial products or provider of commercial services:

Robert J. Birnbaum, MD, PhD: Planner 

John A. Fromson, MD: Planner, reviewer 

Anan Nathif, EdM: Planner 

Tristan Gorrindo, MD: Planner 

Timothy Lynch: Planner 

Tristan Nelsen, Elsevier Office of CME: Planner 

Rob Reina, MS, MBA, Educational Reviewer: Planner 



The following speakers of this activity have indicated that they or their spouse/partner do have a relevant financial relationship to disclose:


Keith T. Flaherty

Consulting Fees:

Roche, GlaxoSmithKline

The following speakers of this activity have indicated that neither they nor their spouse/partner have a relevant financial relationship to disclose:


Donald Lawrence, MD

Jennifer A. Wargo, MD

Hardware/Software Specifications: 

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration: 
Flash Player: Adobe Flash Player 10.1+ 
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+ 
Operating System: Windows XP+ or Mac OS X 10.4+ 
Internet Connection: 1 Mbps or higher

Minimum Requirements: 
Windows PC:
500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera 
Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit


This program has received support in the form of educational grants from the following companies: